鲁西化工所属申万行业为：基础化工-化学原料-煤化工。所属概念板块包括：盐化工、化肥、甲醇概 念、煤化工、磷化工等。 截至6月30日，鲁西化工股东户数10.10万，较上期增加9.83%；人均流通股18860股，较上期减少 8.95%。2025年1月-6月，鲁西化工实现营业收入147.39亿元，同比增长4.98%；归母净利润7.63亿元，同 比减少34.81%。 分红方面，鲁西化工A股上市后累计派现98.85亿元。近三年，累计派现21.67亿元。 机构持仓方面，截止2025年3月31日，鲁西化工十大流通股东中，香港中央结算有限公司位居第三大流 通股东，持股1956.45万股，相比上期增加257.47万股。南方中证500ETF（510500）位居第六大流通股 东，持股1462.82万股，相比上期减少143.69万股。景顺长城中证红利低波动100ETF（515100）位居第 八大流通股东，持股881.04万股，相比上期减少28.56万股。易方达中证红利ETF（515180）位居第九大 流通股东，持股850.11万股，相比上期增加53.29万股。 责任编辑：小浪快报 8月27日，鲁西化工盘中上涨2.11%，截至10:1 ...

沪指本周累计涨3.49%，深证成指累计涨4.57%，创业板指累计涨5.85%。A股后市怎么走？看看机构怎 么说： ①中信证券：此轮行情并不是散户市 中信证券发文称，从各类资金情况来看，此轮行情持续到现在主要的发起者和推动者并非散户；事实上 本轮行情从起步到加速，核心线索都是围绕产业趋势和业绩；既然都是聪明的钱入场占主导地位，就不 能执迷于类比过往行情走势。随着2020~2021年发行的产品整体步入盈亏平衡区域，市场会有个新旧资 金接力的过程；未来行情的延续需要的是新的配置线索，而不是拘泥于"钱多"和流动性。配置上，建议 继续聚焦资源、创新药、游戏和军工，开始关注化工，逐步增配一些"反内卷+出海"品种，9月消费电子 板块也值得关注。 ②光大证券：市场中长期仍然有望持续上行，或以"轮动补涨"特征为主 光大证券研报指出，展望未来，市场仍然有望继续上行。目前来看，支撑股票市场上涨的逻辑并没有发 生变化，市场估值目前也较为合理，并未出现明显透支。此外，还有一些新的积极因素正在出现，如美 联储降息周期可能会开启、公募资金发行出现回暖。综合来看，市场中长期仍然有望持续上行。当前来 看，本轮行情或许会以"轮动补涨"特征为主， ...

8月11日主力资金净流出2254.40万元，近五日主力资金累计净流出3798.38万元。 嘉化能源主营业务涵盖基础化工产品生产与销售、能源供应等。公司位于浙江省，是国内重要的化工企 业之一。 嘉化能源近期发布2025半年度分配预案，拟向全体股东每10股派发现金红利2元，预计派现金额合计为 2.65亿元。此次派现额占净利润比例为45.66%，是公司上市以来累计第26次派现。 嘉化能源股价报8.92元，较前一交易日下跌1.22%。盘中最高触及9.09元，最低下探8.89元，成交金额达 1.82亿元。 风险提示：以上内容仅供参考，不构成投资建议。市场有风险，投资需谨慎。 ...

Core Viewpoint - Lu Xi Chemical has demonstrated significant growth in both revenue and net profit over the years, with a notable increase in its core product segments, particularly in chemical new materials [2][4]. Revenue Structure - The main business of Lu Xi Chemical includes chemical fertilizers, basic chemicals, and fine chemicals, with chemical new materials accounting for the highest revenue share at 68.43%, followed by basic chemicals at 19.47% [2]. Profit Growth - The company achieved a net profit attributable to shareholders of 0.80 billion in its first year of listing in 1998, which grew to 20.29 billion by the latest complete fiscal year of 2024, marking a cumulative growth of 2434.85% over 27 years [2]. - Lu Xi Chemical has not reported a loss in any year since its listing, with 17 years of profit growth, representing 62.96% of the years [2]. Revenue Analysis - In terms of revenue, Lu Xi Chemical reported 175.92 billion in 2020, which increased to 297.63 billion in 2024, showing a fluctuating growth trend with a significant increase of 80.73% in 2021, followed by declines in 2022 and 2023, and a rebound of 17.37% in 2024 [2]. Profit Fluctuation - The net profit attributable to shareholders was 8.25 billion in 2020, rising to 20.29 billion in 2024, with notable volatility; it surged by 459.95% in 2021, then declined in 2022 and 2023, before a strong rebound of 147.79% in 2024 [2]. Market Capitalization - Since its listing, Lu Xi Chemical's market capitalization has increased by 8.50 times, indicating long-term growth potential [4]. - The peak market capitalization reached 491.50 billion on September 23, 2021, with the stock price rising to 25.81 yuan, but as of August 6, the market cap was 229.79 billion, reflecting a decrease of 261.71 billion, or 53.25% from its peak [4].

Core Insights - The report highlights the need for further counter-cyclical policies to achieve the annual economic growth target due to pressures from tariffs, real estate, and limited fiscal capacity [5][8] - The implementation of a national childcare subsidy program starting January 1, 2025, aims to support families with children under three years old, providing an annual subsidy of 3,600 yuan per child [5][8] - The report indicates a moderate recovery in the Chinese economy, with consumption and investment as core drivers, and suggests a favorable environment for medium to long-term investments in the A-share market [5][8] Domestic Market Performance - The Shanghai Composite Index closed at 3,597.94 with a slight increase of 0.12%, while the Shenzhen Component Index rose by 0.44% to 11,217.58 [3] - The average P/E ratios for the Shanghai Composite and ChiNext are at 14.76 and 40.96, respectively, indicating a suitable environment for medium to long-term investments [5][8] International Market Performance - Major international indices such as the Dow Jones and S&P 500 experienced declines of 0.67% and 0.45%, respectively, while the Nikkei 225 saw a slight increase of 0.62% [4] Industry Analysis - The report notes a significant increase in the securities sector, with the securities index rising by 8.85% in June, outperforming the Shanghai Composite Index by 6.35 percentage points [14] - The report anticipates a steady increase in brokerage firms' performance in July, driven by a recovery in trading volumes and an increase in margin financing [15] - The automotive industry continues to show growth, with June production and sales figures reflecting increases of 5.50% and 8.12% month-on-month, respectively [17][18] Investment Recommendations - The report recommends focusing on sectors such as technology growth and cyclical manufacturing, as well as high-dividend banks and public utilities for stable returns [5][8] - In the automotive sector, it suggests monitoring policies that promote sustainable development and the impact of new energy vehicle incentives on consumption [19] - The report emphasizes the potential of the gaming, publishing, and IP sectors, highlighting their strong performance and growth prospects [20][21]

浙江巨化股份有限公司 股票简称：巨化股份 股票代码：600160 公告编号：临 2025－35 2025 年上半年主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露（第十三号化工）》有关规定，将公司 2025 年上半年主要经营数据披露如下： | 主要产品 | 产量 | 同比 | 外销量 | 同比 | 营业收入 | 同比 | | --- | --- | --- | --- | --- | --- | --- | | | 吨 | % | 吨 | % | 万元 | % | | 氟化工原料 | 602145.62 | 11.44 | 187526.53 | 11.72 | 68059.20 | 23.16 | | 制冷剂 | 285057.83 | -5.12 | 154588.31 | -4.19 | 608652.07 | 55.09 | | 含氟聚合物材料 | 69098.79 | 8.49 | 22 ...

Core Viewpoint - The company's capacity construction is steadily advancing, and refined management along with energy-saving measures are continuously enhancing, indicating resilience in the company's performance [1] Investment Highlights - The rating is maintained at "Buy". Due to external environmental impacts on the prices of some chemical products, the EPS for 2025-2026 is revised down to 0.97/1.31 yuan (previously 1.19/1.4 yuan), with a new EPS for 2027 set at 1.36 yuan. Based on comparable company valuations and considering the company's growth potential, a 13x PE valuation for 2025 is given, corresponding to a target price of 12.61 yuan [2] - In 2024, the company's performance is expected to grow by 147.79% year-on-year. The projected revenue is 29.763 billion yuan, a year-on-year increase of 17.37%; net profit attributable to shareholders is 2.029 billion yuan, a year-on-year increase of 147.79%; and the net profit after deducting non-recurring items is 1.962 billion yuan, a year-on-year increase of 126.90%. For Q4 2024, revenue is expected to be 8.184 billion yuan, a year-on-year increase of 10.36% and a quarter-on-quarter increase of 8.57%; net profit attributable to shareholders is projected at 454 million yuan, a year-on-year increase of 45.50% and a quarter-on-quarter increase of 12.46% [2] - In 2024, revenue growth for various product categories is projected as follows: new chemical materials +26.83%, basic chemical products -7.41%, fertilizers +17.85%, and other products +21.84%. Gross profit margins are expected to change as follows: +1.36 percentage points, +2.68 percentage points, -1.41 percentage points, and +2.73 percentage points respectively [2] Performance Resilience - In Q1 2025, the company demonstrated resilience with revenue of 7.290 billion yuan, a year-on-year increase of 7.96% but a quarter-on-quarter decrease of 10.92%. Net profit attributable to shareholders was 413 million yuan, a year-on-year decrease of 27.30% and a quarter-on-quarter decrease of 9.04%. The net profit after deducting non-recurring items was 384 million yuan, a year-on-year decrease of 33.81% and a quarter-on-quarter decrease of 2.40%. The primary reason for the decline was the drop in prices of some chemical products, which fell more than the decrease in raw material procurement prices [3] - The company is steadily advancing its capacity construction, with refined management and energy-saving measures continuously enhancing operations. In 2024, production facilities are expected to operate safely and stably, with successful full-load operation of the caprolactam and nylon 6 phase I project, smooth integration of the silicone project, and orderly progress of the ethylene downstream integration project and 150,000 tons of propionic acid project [3] - The equipment manufacturing business is deeply integrating resources and promoting market-oriented operations of the Luxi Engineering Company, transitioning from serving Luxi to serving Sinochem. The company is expanding exports of new energy equipment and promoting capacity expansion and efficiency improvement [3] - The main raw materials for the company's chemical products include coal, propylene, pure benzene, and methanol. The company focuses on stable cooperation with large state-owned producers to secure channels and strive for price advantages, while also leveraging the proximity of local refining enterprises for cost-effective procurement [3]

Investment Rating - The report maintains a "Buy" investment rating for the company [1] Core Views - The company has experienced significant growth in performance, benefiting from the improved market conditions for refrigerants [1] - The revenue for 2024 reached 24.462 billion yuan, a year-on-year increase of 18.43%, while the net profit attributable to shareholders was 1.960 billion yuan, up 107.69% year-on-year [1] - In Q4 2024, the company achieved a revenue of 6.556 billion yuan, representing a year-on-year increase of 41.21% and a quarter-on-quarter increase of 12.52% [1] Summary by Sections Revenue Growth - The main drivers of revenue growth in 2024 were the expansion of the consolidated reporting scope, increased production, and higher prices. The three main business segments—refrigerants, petrochemical materials, and basic chemical products—continued to contribute significantly [2] - Refrigerant production for the year was 591,400 tons, a year-on-year increase of 21.12%, with external sales of 353,000 tons, up 22.61% [2] - Petrochemical materials production was 607,100 tons, a year-on-year increase of 36.14%, with external sales of 522,100 tons, up 45.70% [2] - Basic chemical products and others produced 3.0402 million tons, a year-on-year increase of 12.90%, with external sales of 1.7852 million tons, up 12.03% [2] Cost Management - The company reduced its sales expense ratio primarily due to decreased leasing costs. The sales/management/financial/R&D expense ratios changed by -0.18%/+0.06%/+0.28%/-0.54% year-on-year [3] Strategic Initiatives - The company is accelerating the production of new projects and enhancing its global HFCs quota advantage to establish a leading position in the refrigerant market. It has successfully completed the acquisition of Feiyuan Chemical, integrating its annual production capacity of 80,000 tons of HFCs and related facilities [4] - The company has also added new products in fine chemicals, significantly increasing the business proportion of fluorinated refrigerants and fine chemical products [4] - The annual production capacity of 85,700 tons of organic alcohol has been successfully put into operation, steadily increasing the domestic market share of organic alcohol products [4] Profit Forecast - The company’s profit forecast has been adjusted upwards, with expected net profits attributable to shareholders for 2025-2027 projected at 3.714 billion, 4.919 billion, and 6.050 billion yuan, respectively. The current stock price corresponds to P/E ratios of 18.5, 14.0, and 11.4 times for the respective years [9]

Core Viewpoint - The company reported significant growth in its first-quarter 2025 performance, driven primarily by the strong demand and price increase of refrigerant products, despite challenges in other chemical product segments [1][2]. Group 1: Financial Performance - In Q1 2025, the company achieved total revenue of 5.8 billion yuan, a year-on-year increase of 6.05% but a quarter-on-quarter decrease of 11.52% [1]. - The net profit attributable to shareholders reached 809 million yuan, marking a year-on-year increase of 160.64% and a quarter-on-quarter increase of 15.22% [1]. - The company's non-recurring net profit was 789 million yuan, reflecting a year-on-year increase of 173.94% and a quarter-on-quarter increase of 9.71% [1]. Group 2: Refrigerant Product Performance - The average selling price and external sales volume of refrigerants in Q1 2025 were 37,500 yuan/ton and 69,800 tons, respectively, representing year-on-year increases of 58.08% and 4.14% [1]. - The company’s refrigerant business saw substantial profit growth, which significantly improved the overall revenue and profit structure [1]. Group 3: Industry Trends - The refrigerant market is experiencing an upward trend in prices, supported by supply constraints due to quota systems and improved industry competition [2]. - As of April 28, 2025, the average domestic market prices for key refrigerants (R22, R32, R125, R134a) increased by 9.1%, 12.8%, 7.1%, and 10.6% respectively since January 2, 2025 [2]. - The export prices for refrigerant R32 showed a gradual alignment with domestic prices, enhancing the company's performance certainty [2]. Group 4: Investment Outlook - The company is positioned favorably within the fluorochemical industry, benefiting from the upward cycle of second and third-generation refrigerants [3]. - Future net profits for 2025-2027 are projected to be 4.908 billion, 5.660 billion, and 6.656 billion yuan, with year-on-year growth rates of 150.47%, 15.32%, and 17.60% respectively [3]. - The company maintains a strong recommendation for investment, highlighting its cost advantages and strategic capacity expansion [3].

股票简称：巨化股份 股票代码：600160 公告编号：临 2025－11 浙江巨化股份有限公司 2025 年 1-3 月主要经营数据公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 浙江巨化股份有限公司（以下简称"公司"）根据《上海证券交易所上市公司 自律监管指引第 3 号——行业信息披露（第十三号化工）》有关规定，将公司 2025 年 1-3 月主要经营数据披露如下： 【注】： 1、同比：指报告期与上年同期相比； 2、外销量低于产量，主要为部分产品作为内部下游产品原料所致； 3、基础化工产品中不含乙炔气、氢气、香精、冷冻油及其他非主要产品（下同）； 4、致冷剂（含全部品种）产量含混配致冷剂产量,产量大于销量主要为部分致冷剂用于公司混配致冷剂原料 所致。 二、主要产品和原材料的价格变动情况 第 1 页 共 3 页 主要产品 产量 同比 外销量 同比 营业收入 同比 吨 % 吨 % 万元 % 氟化工原料 292299.91 13.04 86881.55 11.07 32583.03 26.90 致冷剂 143563.6 ...